Evaluation of SPH3127 in Patients With Mild-to-Moderate Ulcerative Colitis
Public ClinicalTrials.gov record NCT05019742. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Placebo-Controlled Trial to Investigate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of SPH3127 in Patients With Mild-to-Moderate Ulcerative Colitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
SPH3127-US-01 is a multi-center, randomized, double-blind, placebo-controlled study to evaluate the safety, pharmacokinetics, and preliminary efficacy of SPH3127 for the treatment of mild-to-moderate ulcerative colitis.
Study identification
- NCT ID
- NCT05019742
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 3 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 20, 2022
- Primary completion
- Oct 31, 2022
- Completion
- Oct 31, 2022
- Last update posted
- Jun 25, 2025
2022
United States locations
- U.S. sites
- 16
- U.S. states
- 8
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Research Associates, LLC | Huntsville | Alabama | 35801 | — |
| Southern California Research Institute Medical Group, Inc. | Los Angeles | California | 90045 | — |
| Facey Medical Group at Facey Medical Foundation | Mission Hills | California | 91345 | — |
| Precision Research Institute | San Diego | California | 92114 | — |
| Ventura Clinical Trials | Ventura | California | 93003 | — |
| Clinical Research of West Florida | Clearwater | Florida | 33765 | — |
| Velocity Clinical Research | Edgewater | Florida | 32132 | — |
| Homestead Research Institute, Inc. | Homestead | Florida | 33030 | — |
| IHS Health | Kissimmee | Florida | 34741 | — |
| Bayside Clinical Research LLC | Trinity | Florida | 34655 | — |
| Atlanta Center for Gastroenterology, P.C. | Decatur | Georgia | 30033 | — |
| Gastroenterology Associates of Western Michigan, PLC | Wyoming | Michigan | 49519 | — |
| NY Scientific | Brooklyn | New York | 11235 | — |
| Southern Star Research Institute, LLC | San Antonio | Texas | 78229 | — |
| Gastro Health & Nutrition - Victoria | Victoria | Texas | 77904 | — |
| Velocity Clinical Research | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05019742, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 25, 2025 · Synced Sep 13, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05019742 live on ClinicalTrials.gov.